These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 17668563)

  • 21. Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adults in Abidjan, Côte d'Ivoire.
    Castetbon K; Anglaret X; Touré S; Chêne G; Ouassa T; Attia A; N'Dri-Yoman T; Malvy D; Salamon R; Dabis F;
    Am J Epidemiol; 2001 Jul; 154(1):75-84. PubMed ID: 11427407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.
    Djomand G; Roels T; Ellerbrock T; Hanson D; Diomande F; Monga B; Maurice C; Nkengasong J; Konan-Koko R; Kadio A; Wiktor S; Lackritz E; Saba J; Chorba T
    AIDS; 2003 Jul; 17 Suppl 3():S5-15. PubMed ID: 14565604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced morbidity and mortality in the first year after initiating highly active anti-retroviral therapy (HAART) among Ugandan adults.
    Miiro G; Todd J; Mpendo J; Watera C; Munderi P; Nakubulwa S; Kaddu I; Rutebarika D; Grosskurth H
    Trop Med Int Health; 2009 May; 14(5):556-63. PubMed ID: 19320871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte d'Ivoire.
    Grant AD; Djomand G; Smets P; Kadio A; Coulibaly M; Kakou A; Maurice C; Whitaker JP; Sylla-Koko F; Bonard D; Wiktor SZ; Hayes RJ; De Cock KM; Greenberg AE
    AIDS; 1997 Sep; 11(11):1357-64. PubMed ID: 9302446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
    López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA
    J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study.
    Kasirye R; Grosskurth H; Munderi P; Levin J; Anywaine Z; Nunn A; Kamali A; Baisley K
    Malar J; 2016 Jul; 15():361. PubMed ID: 27417903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Compliance in HIV infected adults. Study of opportunistic infection prophylaxis with cotrimoxazole in Ivory Coast].
    Gourvellec G; Anglaret X; Touré S; Huët C; Dakoury-Dogbo N; Lafont S; N'Dri-Yoman T; Chêne G; Salamon R;
    Presse Med; 2004 May; 33(9 Pt 1):595-600. PubMed ID: 15226691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings.
    Ekouevi DK; Inwoley A; Tonwe-Gold B; Danel C; Becquet R; Viho I; Rouet F; Dabis F; Anglaret X; Leroy V
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1469-74. PubMed ID: 18160003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire.
    Minga A; Danel C; Abo Y; Dohoun L; Bonard D; Coulibaly A; Duvignac J; Dabis F; Salamon R; Anglaret X;
    Bull World Health Organ; 2007 Feb; 85(2):116-23. PubMed ID: 17308732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory manifestations in HIV-infected children pre- and post-HAART in Abidjan, the Ivory Coast.
    Kouakoussui A; Fassinou P; Anaky MF; Elenga N; Laguide R; Wemin ML; Toure R; Menan H; Rouet F; Msellati P
    Paediatr Respir Rev; 2004 Dec; 5(4):311-5. PubMed ID: 15531256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.
    Kalou M; Sassan-Morokro M; Abouya L; Bile C; Maurice C; Maran M; Tossou O; Roels T; Greenberg AE; Wiktor SZ; Nkengasong JN
    J Med Virol; 2005 Feb; 75(2):202-8. PubMed ID: 15602734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens.
    Rouet F; Fassinou P; Inwoley A; Anaky MF; Kouakoussui A; Rouzioux C; Blanche S; Msellati P;
    AIDS; 2006 Nov; 20(18):2315-9. PubMed ID: 17117017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thresholds of CD4 cells for initiating trimethoprim-sulfamethoxazole prophylaxis in west Africa.
    Anglaret X; Toure S; Ouassa T; Dabis F; N'Dri-Yoman T
    AIDS; 2000 Nov; 14(16):2628-9. PubMed ID: 11101085
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.
    Yazdanpanah Y; Losina E; Anglaret X; Goldie SJ; Walensky RP; Weinstein MC; Toure S; Smith HE; Kaplan JE; Freedberg KA;
    AIDS; 2005 Aug; 19(12):1299-308. PubMed ID: 16052085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ T-lymphocytes natural decrease in HAART-naïve HIV-infected adults in Abidjan.
    Duvignac J; Anglaret X; Kpozehouen A; Inwoley A; Seyler C; Toure S; Gourvellec G; Messou E; Gabillard D; Thiébaut R
    HIV Clin Trials; 2008; 9(1):26-35. PubMed ID: 18215979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Côte d'Ivoire: a 7-year cohort study.
    Loko MA; Toure S; Dakoury-Dogbo N; Gabillard D; Leroy V; Anglaret X
    AIDS; 2005 Mar; 19(4):443-5. PubMed ID: 15750400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreasing trends of bacteraemia among HIV-infected Ugandan adults: incidence, aetiology, clinical outcomes and effect of antiretroviral therapy in a semi-urban setting (2000-2008).
    Muyanja SZ; Larke N; Rutebarika D; Kaddu I; Nakubulwa S; Levin J; Grosskurth H; Miiro G
    Trop Med Int Health; 2011 Jun; 16(6):756-65. PubMed ID: 21392188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy.
    Mönkemüller KE; Lazenby AJ; Lee DH; Loudon R; Wilcox CM
    Dig Dis Sci; 2005 Feb; 50(2):230-4. PubMed ID: 15745077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.
    Seyler C; Adjé-Touré C; Messou E; Dakoury-Dogbo N; Rouet F; Gabillard D; Nolan M; Toure S; Anglaret X
    AIDS; 2007 May; 21(9):1157-64. PubMed ID: 17502726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.